Twinbeech Capital LP Trans Medics Group, Inc. Transaction History

Twinbeech Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$72.62 - $150.62 $1.91 Million - $3.96 Million	26,321 Added 360.41%	33,624 $5.06 Million
Q1 2024 May 15, 2024	BUY	$70.86 - $89.93 $517,490 - $656,758	7,303 New	7,303 $539,000
Q1 2023 May 15, 2023	BUY	$53.63 - $82.33 $3.02 Million - $4.63 Million	56,233 New	56,233 $4.26 Million

396

31.7M

466K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $1.82B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.